Molecular targeting involves the use of therapies designed to disrupt specific molecules involved in the growth, progression, and spread of cancer cells. Unlike traditional treatments, such as chemotherapy, which target both cancerous and healthy cells, molecular targeting aims to interfere with cancer-specific pathways, minimizing damage to normal cells.
